TrialInternational journal of mycobacteriology

Pharmacodynamic biomarkers for quantifying the mycobacterial effect of high doses of rifampin in patients with rifampin-susceptible pulmonary tuberculosis.

Bibie N Said et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.